RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion The Pharmacology of Longevity: Peptide Edition (Part 1) FDA takes first step in possible reversal of ban on some peptides The Washington Post The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Cost: What You Need to Know